Form EFFECT Moleculin Biotech, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | July 31, 2026 10:00 A.M. |
| Form: | S-1 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moleculin reports 37% blinded remission rate in AML trial interim data
- Natural Grocers® Celebrates 71 Years With Beach-Worthy Savings, Freebies and a Chance to Win a Toyota® RAV4 Hybrid, Aug. 13-15, 2026
- KIDZ AI Signs Data Center MOU with Limestone Networks to Deploy Inference Compute Infrastructure for Open-Weight AI Models, Advancing Its $44.6 Million Canopy Wave Agreement
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
